In this month's "Hot Topic," Kevin Halling, M.D., Ph.D., discusses new next generation sequencing testing for various tumor types and the rationale for the enhancements that were made; reviews gene additions that are now available in each of the panels; and briefly speaks about the work that was done to validate cytology specimens for use in the subpanels.
0:00 Introduction
0:30 Learning objectives
1:24 MayoComplete oncology subpanels
3:03 Test performance characteristics
3:41 Additional genes and full exon sequencing
4:17 Microsatellite Instability (MSI)
5:15 Cytology specimens
6:53 Lung cancer panel
7:31 Colorectal cancer panel
8:03 Melanoma panel
8:40 Gastrointestinal stromal tumor panel
9:00 Sarcoma testing
9:53 Standalone offerings
Негізгі бет MayoComplete Next Generation Sequencing: Oncology Subpanels
Пікірлер